Following the approval of the Pfizer / BioNTech vaccine last year, at the end of December, the UK regulator, the Regulatory Agency for Medicines and Healthcare Products (MHRA), has approved the Oxford vaccine / AstraZeneca vaccine for use in the UK. Health Secretary Matt Hancock described the vaccine’s approval as a “massive step forward” for the UK’s fight against coronavirus, saying vaccines are the “exit path from the pandemic”.
In clinical trials, the Oxford / AstraZeneca vaccine showed a strong immune response in adults of all ages.
The Oxford / AstraZeneca vaccine has a good safety record and has shown 70.4 percent efficacy in tests.
The vaccine was developed by scientists from AstraZeneca and the University of Oxford, and the United Kingdom was the first in the world to sign an agreement for the vaccine.
The approval of the Oxford vaccine was important for the British vaccine’s effort, as the British government ordered 100 million doses of the Oxford / AstraZeneca vaccine – enough to vaccinate 50 million people with two doses.
READ MORE: Coronavirus symptoms of new tension: The sign on your back and chest
Specialists in Wales and Germany then divide the vaccine into vials ready for distribution.
When the Oxford / AstraZeneca vaccine was approved by the British regulator last year, the government took note of its investment in a £ 100 million vaccine factory.
The government said: ‘The UK government has invested £ 100 million to fund a modern manufacturing innovation center in Braintree, Essex, in collaboration with the Cell and Gene Therapy Catapult, to mass-produce a successful Covid to accelerate. 19 vaccine in the UK.
“By December 2021, the center will be able to produce millions of doses of vaccines every month and ensure that the UK has the capacity to produce vaccines and advanced medicines, including for emerging diseases, well into the future.”